IP Library › Granted Patent US 7,696,324
Granted Patent B2
US 7,696,324 · App. 11/519,322 · Granted Apr 13, 2010

Humanized antibodies

Assignee: Perlan Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,696,324
App. No.
11/519,322
Granted
Apr 13, 2010
Kind
B2
Abstract

Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.

Claims (1)

1. A antibody or subsequence thereof comprising SEQ ID NO: 5 and SEQ ID NO: 7.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2010
From: FANG, FANG; KOHLSTAEDT, LORI; RENO, JOHN
To: PERLAN THERAPEUTICS, INC.
Reel/Frame 023880/0695 →
Continuity (3)
Continuation 0991048300 · Jul 19, 2001
Continuation In Part 0955544600
Related Publication 20070071742A1 · Mar 29, 2007